Teva Pharmaceutical Industries Current Ratio 2006-2018 | TEVA

Current and historical current ratio for Teva Pharmaceutical Industries (TEVA) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Teva Pharmaceutical Industries current ratio for the three months ending September 30, 2018 was 0.94.
Teva Pharmaceutical Industries Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-09-30 $13.88B $14.83B 0.94
2018-06-30 $14.71B $14.22B 1.04
2018-03-31 $14.69B $14.76B 1.00
2017-12-31 $15.38B $17.92B 0.86
2017-09-30 $16.23B $16.94B 0.96
2017-06-30 $14.60B $15.46B 0.94
2017-03-31 $14.84B $15.90B 0.93
2016-12-31 $17.23B $18.49B 0.93
2016-09-30 $17.39B $19.29B 0.90
2016-06-30 $18.34B $14.41B 1.27
2016-03-31 $16.99B $12.91B 1.32
2015-12-31 $18.40B $13.01B 1.42
2015-09-30 $12.50B $12.98B 0.96
2015-06-30 $13.30B $14.47B 0.92
2015-03-31 $15.71B $12.47B 1.26
2014-12-31 $14.40B $12.29B 1.17
2014-09-30 $13.92B $11.67B 1.19
2014-06-30 $13.55B $11.85B 1.14
2014-03-31 $13.45B $11.40B 1.18
2013-12-31 $13.72B $11.97B 1.15
2013-09-30 $13.91B $12.16B 1.14
2013-06-30 $14.09B $12.84B 1.10
2013-03-31 $14.42B $12.36B 1.17
2012-12-31 $16.36B $12.89B 1.27
2012-09-30 $14.98B $10.63B 1.41
2012-06-30 $14.23B $10.01B 1.42
2012-03-31 $14.97B $13.63B 1.10
2011-12-31 $14.45B $13.68B 1.06
2011-09-30 $13.02B $11.48B 1.13
2011-06-30 $12.60B $10.05B 1.25
2011-03-31 $12.05B $8.89B 1.36
2010-12-31 $12.04B $9.69B 1.24
2010-09-30 $11.86B $9.32B 1.27
2010-06-30 $14.44B $8.18B 1.77
2010-03-31 $12.61B $8.34B 1.51
2009-12-31 $12.14B $7.60B 1.60
2009-09-30 $11.46B $7.23B 1.58
2009-06-30 $11.04B $7.24B 1.52
2009-03-31 $11.14B $8.57B 1.30
2008-12-31 $11.43B $8.48B 1.35
2008-09-30 $10.95B $4.98B 2.20
2008-06-30 $10.82B $5.46B 1.98
2008-03-31 $10.49B $5.75B 1.82
2007-12-31 $9.86B $5.37B 1.84
2007-09-30 $9.13B $5.22B 1.75
2007-06-30 $8.67B $4.74B 1.83
2007-03-31 $8.02B $4.64B 1.73
2006-12-31 $7.64B $4.07B 1.88
2006-09-30 $7.24B $3.94B 1.84
2006-06-30 $6.67B $3.99B 1.67
2006-03-31 $5.86B $3.68B 1.59
2005-12-31 $5.51B $2.26B 2.44
2005-09-30 $4.40B $2.17B 2.03
2005-06-30 $4.26B $2.09B 2.04
2005-03-31 $4.25B $2.19B 1.94
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $19.738B $22.385B
TEVA Pharmaceuticals USA, the business is to develop, manufacture, and market generic pharmaceuticals. Teva USA sells its products to chains, wholesalers, distributors, hospitals, managed care entities, and government agencies. The company markets a variety of dosage forms, including both extended and immediate release tablets and capsules, creams, ointments, solutions, and suspensions. Key therapeutic areas are the analgesic, anti-infective, cardiovascular, CNS, dermatological and anti-inflammatory categories.
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.409B 8.83
Mylan (MYL) United Kingdom $15.753B 6.49
Bausch Health Cos (BHC) Canada $8.275B 5.99
Dr Reddy's Laboratories (RDY) India $6.267B 24.99
Supernus Pharmaceuticals (SUPN) United States $1.909B 18.08
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.730B 2.88
Amphastar Pharmaceuticals (AMPH) United States $1.014B 109.95
Homology Medicines (FIXX) United States $0.937B 0.00
Assembly Biosciences (ASMB) United States $0.634B 0.00
Akorn (AKRX) United States $0.535B 0.00
CymaBay Therapeutics (CBAY) United States $0.511B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.386B 0.00
Voyager Therapeutics (VYGR) United States $0.349B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.273B 0.00
Sol-Gel Technologies (SLGL) Israel $0.118B 0.00
Teligent (TLGT) United States $0.086B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.085B 0.00
Aevi Genomic Medicine (GNMX) United States $0.077B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.054B 0.00
Acasti Pharma (ACST) Canada $0.052B 0.00
Evoke Pharma (EVOK) United States $0.046B 0.00
Agile Therapeutics (AGRX) United States $0.028B 0.00
Pernix Therapeutics Holdings (PTX) United States $0.005B 0.00